MX246293B - Composiciones y metodos para tratar hiperpigmentacion. - Google Patents

Composiciones y metodos para tratar hiperpigmentacion.

Info

Publication number
MX246293B
MX246293B MXPA03005510A MX246293B MX 246293 B MX246293 B MX 246293B MX PA03005510 A MXPA03005510 A MX PA03005510A MX 246293 B MX246293 B MX 246293B
Authority
MX
Mexico
Prior art keywords
compositions
methods
treating hyperpigmentation
hyperpigmentation
treating
Prior art date
Application number
Other languages
English (en)
Inventor
Ptchelintsev Dmitri
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MXPA03005510A publication Critical patent/MXPA03005510A/es
Publication of MX246293B publication Critical patent/MX246293B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
MXPA03005510 2000-12-20 2001-12-14 Composiciones y metodos para tratar hiperpigmentacion. MX246293B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/741,383 US6562321B2 (en) 2000-12-20 2000-12-20 Compositions and methods for treating hyperpigmentation
PCT/US2001/048382 WO2002049580A1 (en) 2000-12-20 2001-12-14 Compositions and methods for treating hyperpigmentation

Publications (2)

Publication Number Publication Date
MXPA03005510A MXPA03005510A (es) 2004-04-20
MX246293B true MX246293B (es) 2007-06-08

Family

ID=24980507

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005510 MX246293B (es) 2000-12-20 2001-12-14 Composiciones y metodos para tratar hiperpigmentacion.

Country Status (9)

Country Link
US (1) US6562321B2 (es)
EP (1) EP1351647B1 (es)
JP (1) JP2004516259A (es)
CN (1) CN1274291C (es)
AU (1) AU2002236626A1 (es)
BR (1) BRPI0116293B1 (es)
CA (1) CA2429935C (es)
MX (1) MX246293B (es)
WO (1) WO2002049580A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20090092561A1 (en) * 2007-10-09 2009-04-09 Lupia Joseph A Body-care and household products and compositions comprising specific sulfur-containing compounds
FR2928835B1 (fr) * 2008-03-20 2010-05-07 Nuxe Lab Composition depigmentante a base de crocus sativus.
CA2768653C (en) * 2009-08-31 2019-03-05 Avon Products, Inc. Cosmetic uses of modified stressed yeast extracts and related compositions
CA2784899A1 (en) 2009-12-30 2011-07-07 Avon Products, Inc. Topical lightening composition and uses thereof
CN102078486B (zh) * 2011-01-21 2012-06-20 吉林紫鑫药物研究有限公司 一种祛黄褐斑的药物组合物及其制备方法
US9023327B2 (en) * 2012-08-30 2015-05-05 Avon Products, Inc. DICKKOPF-1 expression modulating compositions and uses thereof
US10117821B2 (en) 2013-03-12 2018-11-06 Avon Products, Inc. Topical lightening composition and methods of use thereof
US20150342853A1 (en) * 2014-06-02 2015-12-03 Avon Products, Inc. Topical Lightening Composition and Methods of Use Thereof
EP3463278B1 (en) * 2016-05-29 2020-10-28 Scientis SA Use of thiophosphate derivatives as skin depigmenting agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1000724A6 (fr) 1987-05-20 1989-03-21 Stiefel Lab Ltd Compositions a base de dithranol.
FR2639828B1 (fr) 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
JP2884466B2 (ja) * 1993-12-27 1999-04-19 長瀬産業株式会社 シソ抽出液、その製造方法およびそれを含有する美白化粧料
WO1996007396A2 (en) * 1994-09-07 1996-03-14 Johnson & Johnson Consumer Products, Inc. Retinoid compositions
FR2742750B1 (fr) 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
FR2773323B1 (fr) 1998-01-05 2000-02-11 Oreal Composition contenant une association de procysteine et de polyol
FR2778561B1 (fr) 1998-05-14 2001-04-20 Oreal Azurants optiques comme agents blanchissants
TW591026B (en) 1998-06-23 2004-06-11 Upjohn Co Inhibitors of alpha4beta1 mediated cell adhesion
DE19829789A1 (de) 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6087385A (en) * 1998-10-30 2000-07-11 University Of Mississippi Flavonoid derivatives
DE19929511C2 (de) * 1999-06-29 2003-04-10 Cognis Deutschland Gmbh Hochkonzentriert fließfähige Aniontensidmischungen
CA2413919A1 (en) * 2000-03-21 2001-09-13 Avon Products, Inc. Methods using phytol to improve the appearance of skin and compositions for such methods
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation

Also Published As

Publication number Publication date
JP2004516259A (ja) 2004-06-03
CN1482892A (zh) 2004-03-17
WO2002049580A1 (en) 2002-06-27
CA2429935A1 (en) 2002-06-27
CN1274291C (zh) 2006-09-13
CA2429935C (en) 2011-03-15
EP1351647B1 (en) 2012-11-14
MXPA03005510A (es) 2004-04-20
US20020141953A1 (en) 2002-10-03
BRPI0116293B1 (pt) 2016-07-12
EP1351647A1 (en) 2003-10-15
AU2002236626A1 (en) 2002-07-01
US6562321B2 (en) 2003-05-13
BR0116293A (pt) 2004-08-17
EP1351647A4 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
AP2006003708A0 (en) Methods and compositions for treating flavivirusesand pestiviruses
AU5752601A (en) Splice-region antisense composition and method
ZA200106160B (en) Compositions and methods for treating cataracts.
AU4768301A (en) Synergistic methods and compositions for treating cancer
EP1331278A4 (en) FRESH AND FRESH PROCESSES
AU6832101A (en) Composition and method
MX246293B (es) Composiciones y metodos para tratar hiperpigmentacion.
EP1313477A4 (en) COMPILATIONS AND METHODS
AU4163402A (en) Composition and method
EP1274424A4 (en) CONNECTIONS AND PROCEDURE
MXPA03004401A (es) Metodos y dispositivos para tratar problemas de tartamudez.
PL362855A1 (en) Improved treatment
AU2001275085A1 (en) Methods, compounds and compositions for treating gout
ZA200206252B (en) Method and compositions for treating an inflammatory disease.
EP1253930A4 (en) METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CANCER
GB0118883D0 (en) Method for treating objects
GB0123898D0 (en) Method for treating objects
GB0026838D0 (en) Treatment method
MXPA03004470A (es) Aparato de cerrojo y metodo.
GB0123897D0 (en) Method for treating objects
GB0122810D0 (en) Method for treating objects
GB0020910D0 (en) Reduction method
EP1343796A4 (en) COMPOUNDS AND METHODS
EP1272512A4 (en) IMMUNOKIN COMPOSITION AND METHOD
GB0030956D0 (en) Stain treatment composition

Legal Events

Date Code Title Description
FG Grant or registration